135 related articles for article (PubMed ID: 31184526)
1. An integrated
Dholey Y; Chaudhuri A; Sen Chakraborty S
J Biomol Struct Dyn; 2020 Apr; 38(7):2080-2092. PubMed ID: 31184526
[TBL] [Abstract][Full Text] [Related]
2. Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases.
Hedrich J; Lottaz D; Meyer K; Yiallouros I; Jahnen-Dechent W; Stöcker W; Becker-Pauly C
Biochemistry; 2010 Oct; 49(39):8599-607. PubMed ID: 20806899
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling coupled with molecular dynamic simulation approach to identify new leads for meprin-β metalloprotease.
Chaudhuri A; Hudait N; Chakraborty SS
Comput Biol Chem; 2019 Jun; 80():292-306. PubMed ID: 31054542
[TBL] [Abstract][Full Text] [Related]
4. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10.
Jefferson T; Auf dem Keller U; Bellac C; Metz VV; Broder C; Hedrich J; Ohler A; Maier W; Magdolen V; Sterchi E; Bond JS; Jayakumar A; Traupe H; Chalaris A; Rose-John S; Pietrzik CU; Postina R; Overall CM; Becker-Pauly C
Cell Mol Life Sci; 2013 Jan; 70(2):309-33. PubMed ID: 22940918
[TBL] [Abstract][Full Text] [Related]
5. Exploring protein-protein intermolecular recognition between meprin-α and endogenous protease regulator cystatinC coupled with pharmacophore elucidation.
Chaudhuri A; Biswas S; Chakraborty S
J Biomol Struct Dyn; 2019 Feb; 37(2):440-453. PubMed ID: 29343185
[TBL] [Abstract][Full Text] [Related]
6. Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases.
Karmilin K; Schmitz C; Kuske M; Körschgen H; Olf M; Meyer K; Hildebrand A; Felten M; Fridrich S; Yiallouros I; Becker-Pauly C; Weiskirchen R; Jahnen-Dechent W; Floehr J; Stöcker W
Sci Rep; 2019 Jan; 9(1):546. PubMed ID: 30679641
[TBL] [Abstract][Full Text] [Related]
7. Helical ultrastructure of the metalloprotease meprin α in complex with a small molecule inhibitor.
Bayly-Jones C; Lupton CJ; Fritz C; Venugopal H; Ramsbeck D; Wermann M; Jäger C; de Marco A; Schilling S; Schlenzig D; Whisstock JC
Nat Commun; 2022 Oct; 13(1):6178. PubMed ID: 36261433
[TBL] [Abstract][Full Text] [Related]
8. A combined ligand-based and structure-based
Jana S; Banerjee S; Baidya SK; Ghosh B; Jha T; Adhikari N
J Biomol Struct Dyn; 2024 Jan; ():1-17. PubMed ID: 38165455
[TBL] [Abstract][Full Text] [Related]
9. The metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis.
Broder C; Becker-Pauly C
Biochem J; 2013 Mar; 450(2):253-64. PubMed ID: 23410038
[TBL] [Abstract][Full Text] [Related]
10. Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor.
Linnert M; Fritz C; Jäger C; Schlenzig D; Ramsbeck D; Kleinschmidt M; Wermann M; Demuth HU; Parthier C; Schilling S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073350
[TBL] [Abstract][Full Text] [Related]
11. Shedding light on designing potential meprin β inhibitors through ligand-based robust validated computational approaches: A proposal to chemists!
Adhikari N; Amin SA; Ghosh B; Jha T
J Biomol Struct Dyn; 2018 Aug; 36(11):3003-3022. PubMed ID: 28862075
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal region of human plasma fetuin-B is dispensable for the raised-elephant-trunk mechanism of inhibition of astacin metallopeptidases.
Guevara T; Körschgen H; Cuppari A; Schmitz C; Kuske M; Yiallouros I; Floehr J; Jahnen-Dechent W; Stöcker W; Gomis-Rüth FX
Sci Rep; 2019 Oct; 9(1):14683. PubMed ID: 31604990
[TBL] [Abstract][Full Text] [Related]
13. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.
Kruse MN; Becker C; Lottaz D; Köhler D; Yiallouros I; Krell HW; Sterchi EE; Stöcker W
Biochem J; 2004 Mar; 378(Pt 2):383-9. PubMed ID: 14594449
[TBL] [Abstract][Full Text] [Related]
14. Tertiary-Amine-Based Inhibitors of the Astacin Protease Meprin α.
Tan K; Jäger C; Schlenzig D; Schilling S; Buchholz M; Ramsbeck D
ChemMedChem; 2018 Aug; 13(16):1619-1624. PubMed ID: 29927060
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β.
Tan K; Jäger C; Geissler S; Schlenzig D; Buchholz M; Ramsbeck D
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2165648. PubMed ID: 36661029
[TBL] [Abstract][Full Text] [Related]
16. Insights from Analysis of Binding Sites of Human Meprins: Screening of Inhibitors by Molecular Dynamics Simulation Study.
Chaudhuri A; Bera AK; Sarkar I; Chakraborty S
Comb Chem High Throughput Screen; 2016; 19(3):246-58. PubMed ID: 26875789
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification and initial characterization of human meprin β from Pichia pastoris.
Schlenzig D; Wermann M; Ramsbeck D; Moenke-Wedler T; Schilling S
Protein Expr Purif; 2015 Dec; 116():75-81. PubMed ID: 26256061
[TBL] [Abstract][Full Text] [Related]
18. Two alpha subunits and one beta subunit of meprin zinc-endopeptidases are differentially expressed in the zebrafish Danio rerio.
Schütte A; Lottaz D; Sterchi EE; Stöcker W; Becker-Pauly C
Biol Chem; 2007 May; 388(5):523-31. PubMed ID: 17516848
[TBL] [Abstract][Full Text] [Related]
19. First insight into structure-activity relationships of selective meprin β inhibitors.
Ramsbeck D; Hamann A; Schlenzig D; Schilling S; Buchholz M
Bioorg Med Chem Lett; 2017 Jun; 27(11):2428-2431. PubMed ID: 28408220
[TBL] [Abstract][Full Text] [Related]
20. Meprin α and meprin β: Procollagen proteinases in health and disease.
Prox J; Arnold P; Becker-Pauly C
Matrix Biol; 2015; 44-46():7-13. PubMed ID: 25617491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
